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NOTICE
Statements and views presented in this report are those of the Task Force
members and do not necessarily re ect the views and poiicies of the
Internationai Joint Commission or the Great Lakes Science Advisory Board.
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PREFACE
The Internationai Joint Commission Great Lakes Science Advisory Board's

Task Force on the HeaTth Effects of Non-NTA Detergent Budeers presents its
finaT report. The foTTowing budeers were studied and Chapters contributed by
individuai members of the Task Force, viz:
Carbonates;

CarboxymethyToxsuccinate (CMOS);
CarboxymethyTtartronate (Budeer "M );
Citrates;

Phosphates;

SoTubTe SiTicates; and

ATuminosiTicates (Type A Sodium ZeoTite).
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SUMMARY
l EEQQEEEiQQ
Under the 1972 Great Lakes Water Quality Agreement between Canada and the
United States, measures were taken to reduce the input of phosphorus to the
lakes from municipal sewage; phosphate containing household detergents having
been determined as major contributors.

The consequent restrictions in the use

of phosphate in detergents have led to an increase in the use of alternative
detergent builders.
Three task forces were established by the Science Advisory Board (formerly

the Research Advisory Board) to review the health effects of these materials
resulting from man's exposure to the aquatic environment and to review the
ecological safety of alternative builders in current or projected use, viz:
0

Task Force on the Health Implications of NTA (nitrilotriacetic acid),
final report published, May, 1977;

0

Task Force on the Ecological Effects of Non-Phosphate Detergent
Builders, a report on NTA, December, 1978, studies of other builders
are still underway; and

0

Task Force on the Health Effects of Non-NTA Detergent Builders, final
report due in 1980.

Emeelzsituc sd
The latter task force studied the following builders:
1.

Carbonates

2.

Carboxymethyloxysuccinate (CMOS - Lever Brothers)

3.

Carboxymethyltartronate (formerly Builder "M" - Monsanto Co.)

4.

Citrates

5.

Phosphates

6.

Soluble Silicates

7.

Type A Zeolite (a synthetic aluminosilicate)

The task force was aided in its quest by information provided under the
auspices of the Canadian and U.S. Soap and Detergent Associations,
respectively.

Conclusions were based on present knowledge using current

state-of-the-art techniques in toxicological assessment.
Results and Conclusions

A summary is provided below of the findings of the Task Force on the
Health Effects of Non NTA Detergent Builders as listed above.
1.

Carbonates.

The range of available toxicity studies in experimental

animals is limited.
reported.

No mutagenic or teratogenic effects have been

Carbonates occur naturally in water.

They have a long history

of use as food additives and as such are classified as Generally
Recognized as Safe (GRAS).

Carbonates have

for the treatment of peptic ulcers.

also been used at high levels

It is concluded that the use of

carbonates as detergent builders poses no human health hazard through
their contribution of carbonate to drinking water.
2.

Carboxymethyloxysuccinate

CMOS (Lever Brothers).

The toxicological

studies reported by Lever Brothers indicate that CMOS is essentially
non toxic and produces no demonstrable effects of carcinogenicity,
mutagenicity or teratogenicity.

It was concluded that, based on the Lever

Brothers report, CMOS poses no health hazard to man from chronic ingestion
from drinking water.
3.

Carboxymethyltartronate CMT - Formerly Builder "M" (Monsanto Co.).

This

material is not presently commercially available but may still be a
candidate builder.

Toxicological studies have

been reported by

the

Monsanto Company.
The task force concluded that, from its chemical structure and properties
and the reported results of acute and subchronic toxicity tests, CMT would
not be expected to pose an undue health hazard to man.

The types of tests

performed on CMT have

been appropriate for safety evaluation but the lack

of primary data in most areas,

including chronic toxicity data and

reproductive studies in addition to the unknown genetic risk to man,
precludes full assessment of the potential health affects of this
substance following prolonged exposure by man to the chemical in drinking
water.

Citrates.

Citric acid and its potassium, sodium and calcium salts are

GRAS substances, occurring both naturally and as additives in many foods
and are also normal human metabolites of carbohydrates.

Acute, subchronic

and chronic toxicity tests of citrates show no oral or dermal effects or

eye irritation.

No mutagenic or teratogenic effects have been reported

nor is potential carcinogenicity suspected of citrates.

In acknowledgment of the findings of these studies and of the World Health
Organization's endorsement of an "unlimited" acceptable daily intake of

citrates, the task force concludes that there is no evidence that
ingestion of citrates in drinking water would pose a health hazard to
humans.

5.

Phosphates.
industry.»

Phosphates are ubiquitous in nature and widely used in
They are GRAS substances with allowable daily intakes of 800mg

of phosphorus per day.
300 to 1500mg per day.

Estimates of phosphorus intakes in food range from
Worst-case estimates of phosphorus intakes in

drinking water, assuming extensive use of phosphate in detergents,
suggests intakes of less than 0.01 mg of phosphorus per day.

In view of

this trivial intake, and because animal studies show that very large
quantities by various routes of application show no toxicity,
mutagenicity, teratogenicity or carcinogenicity, it is concluded that

phosphates used as detergent builders should produce no adverse health
effects through their contribution to phosphorus in drinking water.
Soluble Silicates.

Soluble silicates find a wide diversity of uses,

including the food and medicinal industries.

Sodium silicate is used as a

detergent builder.

In the body, sodium silicate is metabolized to and

excreted as silicic acid, which is relatively abundant in nature and a

normal constituent of human urine.
Acute, subchronic and chronic toxicity tests indicate that sodium silicate

is essentially non-toxic.

No mutagenic effects were observed and no data

are available on either teratogenic or carcinogenic effects.

The Select Committee of the Federation of American Societies for
Experimental Biology (FASEB) concluded in a 1979 study that sodium
silicates and certain other silicates used as food ingredients do not
present a public health hazard under current usage. This conclusion
supported the results of an earlier (1974) FAG/WHO toxicological
evaluation of silica and certain silicates used as food additives, which
established no limit for the acceptable daily intake of the silicates
studied except for magnesium silicate and talc. The task force concurs
with these conclusions in regard to the human health safety of soluble
silicates used as detergent builders and their potential contribution of
silicon to drinking water.
Type A Zeolite (a synthetic aluminosilicate).

Aluminosilicates are widely

utilized in the food industry and in treating drinking water, not posing a
human health hazard under current conditions of use.

Cubic Type A

Zeolite, with a Na:Si:A1 ratio of 1:1:1 is thermodynamically less stable
than food grade aluminosilicate, with its corresponding ratio of 1:1:13,

rapidly forming soluble aluminates and silicates in aqueous suspensions at
a pH <8; hence rarely being found in the environment.
Type A Zeolite is essentially non-toxic in chronic toxicity tests on

animals, the behaviour being representative of the silicates formed on
hydrolysis rather than that of the aluminates.

No carcinogenic or

teratogenic effects result from Type A Zeolite exposure and it is unlikely
to produce mutagenic behaviour.

Considering the normal exposure of man to natural

silicon compounds

without evident health hazards and the miniscule increase in silicon
levels in drinking water resulting from the proposed use of Type A Zeolite
in detergents, the task force concludes that use of this zeolite in
detergents is not anticipated to lead to adverse human health effects.
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1. INTRODUCTION

During the last two decades it has become clear that phosphorus is one of
the principal nutrients contributing to the process of eutrophication observed
in many inland waters, including The Great Lakes.

While phosphorus loadings

to the lakes have many origins, the contribution through domestic wastewater

was identified as one of the principal sources.

In recognition of this, the

1972 Great Lakes Water Quality Agreement between Canada and the United States
called for the development and implementation of waste treatment programs and
other measures to reduce inputs of phosphorus to the lakes from municipal
sewage.

Phosphate-containing detergents were identified as one of the main

sources of controllable wastewater phosphorus.

It was thought that

restrictions on this detergent use of phosphate would immediately reduce
phosphorus loadings to the lakes in the absence of the wastewater treatment
technology and treatment plants with the capability to reduce the phosphorus
from all sources in municipal wastewater to an acceptable effluent level.

The

restrictions which were therefore imposed on the use of phosphate in
detergents have resulted in the increased use of alternative detergent builder
materials and their consequent release to the aqueous environment.
The International Joint Commission Science Advisory Board created three
task forces to investigate the state of knowledge of the health and ecological
effects of the builder materials being used or that were anticipated to be
used as a result of the restriction on the use of the phosphate materials.
A Task Force on the HEALTH IMPLICATIONS OF NTA AS A DETERGENT BUILDER has
completed its study and reported its findings to the IJC in July 1977.
(Reference:

"A Report to The Great Lakes Research Advisory Board of the

International Joint Commission on the Health Implications of NTA May 1977".)

In response to this report, the Science Advisory Board concluded, "the Board's

conclusion that on the basis of health hazard there is no reasonable cause for
restricting the use of NTA as a replacement for phosphate in detergents in The
Great Lakes Basin".

(Reference:

Board, IJC, July l977).

Annual Report of the Research Advisory

A second Task Force on the ECOLOGICAL EFFECTS OF NON-PHOSPHATE DETERGENT
BUILDERS has completed its study of NTA and recommended, "that NTA should not
be prohibited from use as a detergent builder."
Effects of Non-Phosphate Detergent Builders:
December 1978.)

(Reference:

Ecological

Final Report on NTA, IJC

This second task force has continued its study of materials

other than NTA.
This third Task Force on the HEALTH EFFECTS OF NON NTA DETERGENT BUILDERS
was established to consider the health effects of detergent builder materials
other than NTA that are currently in use or are likely to come into use.

This

third task force consisted of scientists selected from areas that address the
health effects of such materials.

In addition, to facilitate awareness of

unpublished data and ongoing research being conducted by industry and
governments, liaison members were solicited from the Soap and Detergent
Associations of Canada and the United States and appropriate federal agencies
from the two countries.

Adjunct

members with specific areas of expertise were

added to assist the task force in its review.

Appendix B lists the task force

and liaison members and Appendix A lists the terms of reference of the task
force.
Seven materials were identified for examination by
organic polycarboxylate builders other than NTA

the task force:

the

citrate, carboxymethyloxy

succinate (CMOS), and carboxymethyltartronate (Builder M), and the inorganic
builders - carbonate, silicate, aluminosilicate (Type A Zeolite) and phosphate.
One procedure followed by the task force was to arrange industry and/or
company presentations on the current, known, information available on the
health effects of these materials.

These were arranged either as meetings

with written summaries or as summaries provided only in written form.

Task

force and adjunct members reviewed this information and discussed and queried
pertinent aspects.

Another procedure was to undertake research of available

information through computer assisted reviews of the published literature and
through specially arranged conferences.
The findings of the Task Force on the Health Effects of Non-NTA Detergent
Builders are presented in the following chapters.
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2.CARBONATES *

Introduction

The avaiiabTe information on the bioTogicaT effects of "carbonates" has
been summarized in the GRAS Monograph and in the $0003 (Seiect Committee on
GRAS Substances) Report.

These reports were prepared for the U.S. FDA, as

information has been abstracted from this document.

The foTTowing

It is considered to be

the most reTevant for evaTuating the possibTe heaith effects of carbonates to

._..

man.

,, 1M

Information Service, U.S. Department of Commerce, VA 22151.

.,

The documents are availabTe from the NationaT TechnicaT

. ., .
"5%W

Safe) food chemicais.

A ._N ..5;_.~«,{y :3,
zim

part of its ongoing survey of the safety of GRAS (GeneraTTy Recognized as

.42»

Environmentai Leveis

The major source of exposure of man to carbonates and bicarbonates is
through the diet (food and water). The average dietary intake of carbonates
and bicarbonates by aduTts through their use in food may exceed lg/day. This
may be a gross overestimate, since this is based on (a) totaT usage based on

the amount used in foods and (b) totaT consumption in 1970 and a U.S.
popuiation of 210 miTTion. The actuaT TeveT depends on the nature of the diet
and frequency with which certain foods are eaten, as weTT as the
characteristics of the food preparation process since carbonates and

bicarbonates, which are often used as Teavening agents, are no Tonger present

in the processed food (1). The normai TeveT of carbonate and bicarbonate in
raw drinking water ranges from 0-1 mg/L, at 15-322 mg/L, respectiveiy ((2)
TabTe 1).

Estimates of the contribution of detergent carbonates to environmentai
TeveTs of carbonates, based on an average TeveT of 20% on aTT granuiar Taundry
detergent, show that the contribution to raw sewage woqu be 9.3 mg/L, and to

surface water, 0.0093 mg/L (TabTe 2, (3)).
*Contributed by 5.1. Shibko

3:5

TABLE 1

C03_ AND HC03- CONCENTRATIONS IN RAW DRINKING WATER SUPPLIES

C03

ID

Avg.

134

Newark, N.J.

132

Richmond, VA.

95

111
118

Charlotte, N.C.

AtTanta, Ga.
Avg.

OOOO

Buffan, N.Y.

io

Detroit, Mich.

lI

Chicago, I11.

C03

HC03_

OI

Miiwaukee, Misc.

Mid-West
mg/L

Eastern Coast
mg/L

Great Lakes
mg/L

C03

HC03_

HC03_

O

322

Iowa 0

340

20

Kansas City, Mo. 0

198

15

Omaha, Neb.

0

2§§

23

Topeka, Kan.

41

Des Moines,

25

Avg.

275

TABLE 2

CARBONATE IN LAUNDRY DETERGENTS
RAW SEWAGE AND SURFACE WATER LEVELS RESULTING FROM THE USE OF SODIUM
I.

Bases

U.S. Laundry Detergent Market Vqumel:
Product Composition:

U.S. PopuIationZ:

3 x 109 1b./yr. (1974)

20% Na2C03

211, 381, 000 (JuIy l, 1974)

U.S. Sewage FIow3:

100 gaI/capita/day

11

U.S. Sewage Effluent DiIution (Avg.) = 1:100
II.

Ca1cu1ation - Raw Sewage
9

3 X 10

Tb detergent

year

Na2C03

X 0 20 detergent

3

x 454 g/Ib x 10 mg/9

gaI
211 x 106 capita x 100 gaI/cap/day x 365 days /year x 3.79 Iitres/
III.

Surface Waters

CaIcuIation

9.3 hug/L x

1
10

= 0.093 mg/L

= 9.3 mg/L

Acute Toxicity
L050

Substance
Potassium
carbonate
Sodium
bicarbonate

Animal

No.

Route

(Dosage mg/kg
body weight)

Ref.

rats

unk.

oral

1870

(4)

rats

unk.

oral

4300 (a)

(5)

bicarbonate

rats

unk.

oral

6000 (b)

(5)

bicarbonate

rats

unk.

oral

5500 (c)

(5)

bicarbonate

rats

unk.

oral

4850 (d)

(5)

bicarbonate

rats

unk.

oral

5900 (e)

(5)

Sodium
Sodium

Sodium

Sodium

a

in a 20% slurry

c
d
e

dose volume 20 mL/kg
dose volume 50 mL/kg
dose volume 20 mL/kg + 30 mL water

b

in a 50% slurry

Subchronic Toxicity and Metabolism

The available data in mammalian species is extremely limited. Calcium
carbonate fed to rats at a dietary level of 3% for 4 months resulted in
suppression of growth. The decrease in growth may have been due to an
imbalance in the Ca/POu ratio, since no additional phosphate was added to

the experimental diets (6).
into the metabolic pool.

C from Cl

carbonates, is readily incorporated

It is mainly excreted by respiration, but some is

incorporated into liver glycogen, fats and proteins (7).
Reproduction Studies

Swiss white mice were fed diets containing 0, 0.5, 1 and 1.9% calcium
carbonate. There was a significant decrease in the total weight of the young
at weaning in the 1.9% group.

The same effect was observed in subsequent

litters.

Autopsy of the offspring at 21 days of age, in the 1.9% group,
showed pale speckled livers, enlarged heart and small thymus glands (8).

12

Chronic Toxicity and Carcinogenicity
No data available.
Mutagenicity

The genetic activity of sodium bicarbonate and potassium carbonate was
assessed in microbial assays, with and without the addition of mammalian
metabolic enzymes. The indicator organisms used for the tests were
Saccharomyces cerviseae,

strain D4,

TA-1535, TA-1537 and TA-1538.

and Salmonella typhimurium, strains

Sodium bicarbonate and potassium carbonate were

not mutagenic either directly or in the presence of organ homogenates in any

of the in vitro systems tested (9).
Teratogenicity

The following studies have

been carried out to evaluate the possible

teratogenic effects of sodium carbonate and sodium bicarbonate:
Sodium bicarbonate

Albino mice (CD l outbred mice) were dosed on day 6-15 of gestation by
oral intubation at dose levels of 5.80, 27.0, 125.0, or 580.0 mg/kg.

w
,\

Albino mice (CD-1 outbred mice) were dosed on day 6-15 of gestation by
intubation with dose levels of 3.40, 15.8, 73.4, or 340.0 mg/kg.

"
.

oral intubation at dose levels of 2.45, 11.4, 52.9, or 240.0 mg/kg.

,

Albino rats (Wistar derived stock) were dosed on day 6-15 gestation by

.

..

oral

c
, v '
V 2H,; aggr- ..s ,-»{'
.A h- r1."
<,.-.-' ..AFR.1

1

Sodium carbonate

J}. L,
..-..my,

oral intubation at dose levels of 3.40, 15.8, 73.3, or 340.0 mg/kg.

1

Albino rats (Wistar derived stock) were dosed on day 6-15 of gestation by

13

Sodium bicarbonate

Dutch-belted rabbits were dosed on day 6-18 of gestation by oral
intubation at dose levels of 3.30, 15.3, 71.2, or 330.0 mg/kg.
l or
Parameters evaluated included fetal mortality, internal, externa
No fetacidal or teratogenic effects were reported (10).
skeletal alterations.
Studies with Man

The available information is primarily derived from the effect of an
extremely high dosage carbonate treatment on peptic ulcer patients. 2,300
mg/kg NaHCOa administered daily for 3 weeks to 33 patients resulted in
marked alkalosis but no other adverse effects. Although the glomerular
filtration rate increased on dosing, no renal damage was detected (11).

In another study, one individual received 32,000 g of sodium bicarbonate
over a period of 20 months without any effect on acid-base balance, urea
clearance, or red and white blood cell counts of hemoglobin (12).

00 mg/kg
Normal humans absorbed 8-18% of a single oral dose of 16.6-2

CaC03 (13). Patients with mild alkalosis absorbed 12-37% of the dose
onate
(14). At plasma levels below 24 uM/L in man, essentially all bicarb
from sodium bicarbonates entering the renal tubule is absorbed.

level, the excess bicarbonate is excreted.

Above this

Ingestion of high levels of sodium

calcium
bicarbonate has caused potassium retention and decreased excretion of
in the urine.
Summary

The range of available studies in mammalian species including man is quite
limited, and does not meet the usual requirements for safety evaluation.
However, the use of carbonates and bicarbonates at extremely high levels for
the treatment of individuals with peptic ulceration indicates no adverse
In normal
effects other than transient changes in acid base ratio.

14

individuals, bicarbonate is readily metabolized and excreted through the lungs
as C02 or through the kidneys. Abnormal effects reported in experimental
animals fed calcium carbonate appear to be related to the excess calcium,

causing a mineral imbalance, rather than to carbonate or bicarbonate per se.
Conclusions

The available biological data indicate that the present day human exposure
to carbonates and bicarbonates from food and other sources does not pose a
health hazard.

No hazard is anticipated from the use of carbonates and

bicarbonates as detergent builders, through their contribution to the loads of
carbonates and bicarbonates in drinking water.
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3. CARBOXYMETHYLOXYSUCCINATE (CMOS)*

Introduction

A potential detergent builder developed recently, it is empirically
isomeric with citric acid.

The structure is shown in Figure 1.

It should be

noted that the abbreviation "CMOS" stands for the tricarboxylic anion.
CHz-COONa

CHz-COONa

IH COONa

OHC-COONa

9

CHz-COONa

CHz-COONa
Sodium CMOS**

Sodium Citrate
FIGURE 1

Lever Brothers have carried out the development work on CMOS and it is

their view that this material may be used as a phosphate replacement.

Data in this review have been taken from a summary report by Lever
Brothers presented in the United States Department of Health, Education and

Welfare Committee to Coordinate Toxicology and Related Programs, January 25,
1977, as well as primary data supplied by the Company. Although the Company
has presented the toxicology information in some detail, the material has not

been published for peer review.
Environmental Levels

the
Although the trisodium salt of CMOS is used in detergent products,

sodium calcium salt (NaCaCMOS) will be the chemical species found in the wash
*

Contributed by G.C. Becking

** Trisodium 2-oxa 2,3,4-Butanetricarboxylate
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water and the environment.

The polarity and metabolic fate in the environment

precludes bioaccumulation or biomagnification in mammals.

Environmental

levels will range from 0.015 to 0.18 mg CMOS/L in receiving streams depending
on whether secondary or primary sewage treatment is utilized.

Based on the

metabolic fate of CMOS, levels in drinking water are unlikely to exceed 0.05
mg/L.

5292119112111
Lever Brothers have studied in some detail the acute toxicity of CMOS
salts in several animal species.
Table 1.

The results of these tests are summarized in

It is apparent that CMOS salts are not acutely toxic to mammals.
TABLE 1
ACUTE TOXICITY 0F SODIUM CMOS

Test

Species
(M&F)

Result

Comments

Oral L050

Rat

2.4-3.5 g/kg

LD50 NaCa CMOS (species in the

Skin irritation

Rabbit

Nonirritant

Intact and abraded skin utilized

Eye irritation

Rabbit

Nonirritant

Cornea, Iris and Conjunctiva studied

Acute Dermal

Rabbit

LDso>5.Qg/kg

No lethality at 5.9 g/kg

Acute Inhalation

Rat

6-hr LCso 3
>8.25 g/m

No lethality at 8.25 g/m3

Sensitization

Guinea

Nonsensitizing

Intradermal

Pig

environment) = 29.5 g/kg

injection

Detergent formulations containing sodium CMOS were tested for consumer
safety.

Powdered formulations, similar to those available commercially, but

containing CMOS, were essentially non-toxic with an oral LC
rats.

>5g/kg in

They were noncorrosive in an esophageal corrosivity tgst, were only

mild-to-moderate irritants in an occluded rabbit skin test and were only
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slightly irritating to rabbit eyes.
safety of CMOS containing detergents.

Human patch tests further confirmed the
Detergent formulations containing

sodium CMOS were both nonirritating and nonsensitizing.
Subchronic Toxicity and Metabolism

Subchronic studies in rats at doses of sodium CMOS up to 1.0 g/kg for 30
days and 4.5 g/kg for 10 days indicated minimal toxicity for this material.
In the ten day rat studies, marked diarrhea, decreased growth rate and

increased spleen weight were noted only at doses approaching the LDso
(2.6-4.5 g/kg).

No changes in histopathology, hematology or urinalysis were

reported, but an increase in blood urea nitrogen and a decrease in serum

globulin was observed in male rats fed 1.0 g/kg/day for 30 days.

The

conclusion that CMOS exerts its minimal toxicity via a non-specific
disturbance of pH, mineral and water balance related to its chelating

properties seems reasonable, although data substantiating this hypothesis are
lacking.

The biological fate of sodium CMOS was investigated in the rat, monkey and
man. Tissue levels were determined only in the rat.

No alterations in tissue levels or metabolism of CMOS were seen in rats
fed CMOS for six months compared to controls. This indicates that CMOS does
not induce enzyme systems involved in metabolizing this chemical.

Table 2.
Results of the absorption/excretion studies are presented in
on and
After 72 hours, only traces of CMOS were found in the rat skelet
rapidly
vital organs; it is therefore apparent that, even if absorbed, CMOS is
55% of the CMOS
and completely cleared from the mammalian body. Approximately
etates,
absorbed by the rats was metabolized, primarily to oxalates and oxaloac
is
whereas in primates, including man, little is absorbed and that which
absorbed is excreted as unchanged CMOS.
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TABLE 2
MAMMALIAN ABSORPTION AND EXCRETION OF CMOS

Species

No. of
Subjects

Rat

3

Monkey

3

Man

3

Percent of Dose Excreted
Urine
Feces
24 hr 24-72 hr 24 hr 24 72 hr

Dose

25 mg;

12 uCi

0.1.
Tract

TotaT

71.2

2.3

26.9

1.9

-

102.3

487 mg; 232 uCi

2

2

9

53

30*

96

500 mg

2

1

not assayed

*average recovery from the GI tracts of monkeys at necropsy 72 hr post dosing
(range 24-45%)

Chronic Studies

ATthough three separate chronic studies were carried out in rats, the
appropriateness of the maximum dose utiTized (300 mg/kg) and the materiaT
tested shoqu be examined.

It is true

that no pathoiogicai Tesions were noted

in 6, 12 and 24 months, but is unusuai to carry out a chronic toxicity study

where no overt signs of toxicity were noted in the high dose animaTs.
Tack of observed toxicity

The

maysimpTy be an indication of the reTative

non-toxicity of CMOS, but such an hypothesis requires experimentai
verification.
appropriate.

The use of NaCaCMOS in chronic toxicity studies woqu seem
From the physicai

chemicaT properties of CMOS it can be

caicuTated that man wiTT be exposed to the CaCMOS ion, not to the CMOS species.
No toxicity was noted in maie or femaTe rats fed diets containing 63, 250,

1000 or 4000 mg CMOS/kg diet for six months.
(the probabTe environmental species) was

In a 16 month study NaCaCMOS

fed at 1000 and 5000 mg/kg diet to

maTe and femaTe rats prior to and after mating, as weTT as to the progeny for
16 months.

No treatment-reTated toxic response was noted.

In the finaT

chronic toxicity test, maTe and femaTe rats were fed diets containing 22, 216

and 3600 mg CMOS/kg for one year and diets containing 25, 246 and 4100 mg
NaCaCMOS for another year.

A smaTT decrease in ovary weight was noted, but no

morphoiogicai changes were noted in the tissue sections.
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When evaluated on the basis of growth rate, food consumption, survival,
gross observations, hematology and gross and microscopic observations of
tissue, it was concluded that levels of CMOS as high as 3600/4100 mg
NaaCMOS/NaCaCMOS/kg of diet caused no significant chronic adverse effects
in rats.
The effect of CMOS salts on reproduction in rats was studied in a three
generation study.

No alterations in fertility, gestation, viability or

lactation indices were reported when Na3CMOS and NaCaCMOS were fed at
dietary levels of 63, 250,

results were corroborated.

1000 and 4000 mg/kg.

In a second study, these

Also in the latter study, no teratogenic effects

were reported in the Fla generation after feeding diets containing 3600 mg

NaaCMOS/kg of diet.

The Company concludes that CMOS salts do not

adversely effect the reproductive ability, nor the embryonic and fetal
development in rats.

Such a conclusion seems reasonable, in view of the

results of specific teratogenic experiments to be reported later in this
reView.
Carcinogenicity

The Company has reported no significant differences in tumour incidence
between control and animals consuming diets containing levels of N63CMOS

and NaCaCMOS as high as 3600 and 4100 mg/kg. The lack of tumour pathology in
the 16 month, two-generation chronic toxicity study can be taken as furter

evidence of the non-carcinogenicity of CMOS salts.

Before one can fully

doses
accept such negative data, it is imperative to ascertain whether these
approached the maximum tolerated level. That is, a dose where some minimal

target organ toxicity, or other manifestation of minimal general toxicity was
noted.
Mutagenicity

The mutagenicity of NaaCMOS and NaCaCMOS was studied in Salmonella
typhimurium strains TA200, 1538, 1535, 98, and 1537 at levels up to
Both
4000 pg/plate with and without activation by mammalian microsomes.
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compounds were nonmutagenic.

In the host-mediated assay utilizing §L
typhimurium TA 1530 and 0-46, as well as Saccharomyces cerevisiae 0 3, no
mutagenicity was noted after dosing mice with 4, 40 or 400 mg/kg body
weight/day.

No chromosome aberrations were noted in male rats fed diets containing
levels of NaCMOS as high as 500 mg/kg for 3 generations.
After six months exposure of male rats to dietary levels of NaacMOS or
NaCaCMOS of 4000 mg/kg, no mutagenic activity was noted in a dominant lethal

test.

It was concluded that CMOS did not pose a mutagenic hazard to man. The
negative mutagenicity data also support the negative carcinogenicity data
discussed previously.
Teratology

Extensive teratology experimentation, using several protocols, was
reported by Lever Brothers. The teratological potential of
NaacMOS,
sodium citrate, distilled water and Vitamin A were compar
ed in rats.

While

Vitamin A caused a significant number of teratogenic changes,
no such adverse

effects were seen in the water control, CMOS or citrate
dosed animals.

Doses

of NaCMOS up to 300 mg/kg were given between days 6-15 of
gestation, and doses
of NaCMOS as high as 1000 mg/kg were administered to rats
between days 1-7,
7-14, 14-21 and 1-21 of gestation (period of organogenesi
s). No mobilization

of heavy metals by CMOS was reported, nor was
toxicity noted in the hamster.

any potentiation of cadmium

Summary

Lever Brothers have concluded, on the basis of their
toxicological
examination, that CMOS poses no hazard to man from chron
ic ingestion from
drinking water. Acute toxicity was similar to other
builders now in use.
Based on their summary report, and the primary data avail
able this conclusion
is probably valid.

22

4. CARBOXYMETHYLTARTRONATE (Builder M )*
Introduction

Monsanto has developed a new polycarboxylic acid detergent builder, called
carboxymethyltartronic acid (CMT).

This builder has often been referred to as

Builder "M", and the structures of the major components are shown in Figure 1.
$00Na
H$-

O-

$00Na
~ CH2

COONa

EOONa
HC-

$00Na

O .

$H

OONa

Sodium Carboxy-

methyltartronate
(NaCMT - 76%)

$00Na
2HC__.0

$00Na
CH2

COONa

Sodium Ditartronate

(7%)

Sodium Diglycolate

(3%)

Figure 1

The builder is composed of all three chemicals shown in Figure 1.

The term

CMT used in this report refers to the mixture used in detergents.
At present, this material is not commercially available, but given the

proper economic situation, the chemical properties of CMT as a builder might
place it in a competitive position with other chemicals. For this reason, a
discussion of the human health aspects of this builder seems in order.

Monsanto Company has informed the Task Force that research is still
proceeding on CMT, but with a very low priority. The only report available on
CMT was prepared by Monsanto (Builder
March 1978).

M , Environmental and Human Safety,

No primary toxicological data have been reviewed, nor have any

of the test results been published for peer review.

mg
It has been estimated that drinking water could contain less than 0.02
CMT/L under use conditions where all detergents contained 25% w/w CMT. Based

*

Contributed by G.C. Becking
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Environmental Levels

on chemicaT properties and economic factors, CMT woqu never be used at this
TeveT.
Acute Toxicity

The oraT L050 for CMT in rats has been reported as 2-3 g/kg whiTe the
dermaT MLD in rabbits was found to be greater than 8 g/kg.

as non-irritating to rabbit eyes and skin.

CMT was reported

No evidence of primary irritation,

fatiguing or sensitization was found in 200 human subjects.
Subchronic Toxicity and Metaboiism

Monsanto has carried out 90 day feeding studies in dogs and rats. The rat
appeared to be more sensitive to CMT than dogs. No adverse effects were
reported in dogs fed diets containing 10,000 mg CMT/kg for 90 days, whereas a
no-effect TeveT in rats of 3000 mg/kg diet was reported. The onTy adverse
effect in rats fed CMT at 10,000 mg/kg diet was an increased urinary excretion
of caTcium.

In a 30-day study, rats were fed diets containing 3000 mg CMT/kg

diet and no enhancement of methyT mercury toxicity by CMT was noted.

In aTT

subchronic studies, the indicators of toxicity were mortaTity, gross and

histopathoiogy, hematoTogy and urinaTysis.
MetaboTism data on CMT are minimaT, based onTy on singTe doses of

C-TabeTTed CMT administered to rats.

In such experiments, 90 percent of

the dose was excreted in 48 hours; 58 percent in the feces and 32 percent in

the urine.

It is stiTT not certain whether the excreted materiai is unchanged
CMT or various metaboTites.
Chronic Toxicity and Carcinogenicity

The chronic toxicity and carcinogenicity tests have not been reported in
finaT form. A 2-year rat study and an 18-month mouse study at NaCMT dietary
TeveTs between 1 and 10 g/kg were to be completed in 1979. A 2-year study in

rats, where drinking water contained 1.7g/L of NaCaCMT, was aTso due to be
compieted in 1979. The onTy information received to date indicates that no

compound-reiated, in Tife toxic signs were noted in these chronic studies.
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Mutagenicity

The sodium and calcium salts of CMT have been tested for potential
mutagenicity in five strains of Salmonella typhimurium and Saccharomyces

cerevisiae D-3 with and without metabolic activation.

Even when 5 percent

solutions of NaCMT were studied, results were negative.
Dominant lethal tests in mice fed diets containing 5 g NaCMT/kg or
presented drinking water containing 1.7 mg CaCMT/L were negative.

Also, after

8 weeks of dosing, no chromosome aberrations were found in bone marrow cells.
At a level of 1.7 g NaCaCMT/L in drinking water, two reciprocal
translocations were noted in 400 F1 male mice.
obtained at 0.17 g NaCaCMT/L.

Negative results were

The significance of these results is as yet

unknown.
Teratogenicity

The teratogenic potential of CMT was studied in rats and rabbits, using
fetal mortality, internal, external or skeletal alterations as indicators of

teratogenicity.

Doses of 100-1000 mg NaCMT/kg were given orally to rats

between days 6-18 of gestation.
noted.

No fetacidal or teratogenic effects were

Similarly, no fetacidal or teratogenic effects were reported in

rabbits given oral doses of l00-300 mg/kg between days 6 18 of gestation.

In the rat, an oral dose of 100 mg/kg of NaCMT did not alter the classical
toxicity and teratogenic effects of methyl mercury.

Monsanto Company has reported that multigeneration reproductive studies
are in progress.

No experimental results are available.

Summary

From its chemical structure and properties, and the results of acute and
subchronic toxicity tests, one would not expect CMT to pose an undue health
hazard to man. The types of tests carried out on CMT have been appropriate
25

for safety evaiuation but, given the lack of primary data in most areas, the
lack of chronic toxicity data and reproductive studies, as weH as the unknown
genetic risk to man one cannot assess quy the potentia] heaith effects of
CMT after continua] exposure to this chemicai in drinking water.
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5.CHRATES*

Lntngdustigu
This report concerns the health aspects of using citric acid and its salts
as builders in household detergents. The most extensive uses for citrates are
in the food and pharmaceutical industries. Citrates effectively chelate most
divalent and trivalent ions (1), thus making effective detergent builders.

Other industrial uses include metal cleaning, electrolytic polishing and
plating, dyeing, water treatment and other miscellaneous industrial processes.

Citrates (particularly sodium and potassium) are ubiquitous in nature,
appearing in small amounts in most organisms.

Citrate is a normal metabolite

in most lifeforms during the metabolism of carbohydrate.
Environmental Levels

In general, ambient citrate levels in the aquatic environment range
0.145 mg/L, while values as high as 8.7 mg/L have been
between 0.025
has been
reported (2). The median citrate concentration in sewage effluent

found to be 0.2 mg/L.

Citrate levels as high as 10 mg/L are rapidly degraded

to normal ambient levels (2).
ent use would be
Long-term human exposure to citrate resulting from deterg
0n the average, drinking
primarily oral, through ingestion of drinking water.
would increase to 0.0085
water contains 0.002 - 0.005 mg citrate/L and this

(2).
mg/L if all detergents were built with 25% citrate

If this occurred

citrate/day from his drinking
without degradation, man would consume 0.02 mg
water, compared to 4.5 g from food sources (3).
*

Contributed by G.C. Becking
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Acute Toxicity

A succinct summary of the acute toxicity of citrates is presented in a

report to the Food and Drug Administration (3).
citrate in mice was 7.1 g/kg.

The era] L050 of sodium

A11 mice receiving 4.8 g citrate/kg survived.

Another study indicated the ora1 LDso for citric acid in mice was 5 g/kg
and in rats as 12 g/kg.

The signs of acute toxicity from citric acid in mice

and rats are those of organic acidosis and ca1cium deficiency.
Acute oraT toxicity studies of citric acid in man have not been reported,
but daiTy doses of potassium citrate as high as 10 9 have been used to render

urine Tess acid and as a mde diuretic (4).
Subchronic Toxicity

Rats administered citric acid in the diet (0.6 g/kg body weight) for 90
days exhibited no significant changes in body weight gain, bTood parameters,
histopathoTogy or reproduction (5).

No behaviouraT, biochemica] or histo-

pathoTogicaT abnormaiities were produced in dogs fed citric acid, 1.38 g/kg,

for 112-120 days (4).

'

It has been reported that citric acid fed to rats at a TeveT of 4.67 g/kg
body weight for 6 weeks produced a siight thymus atrophy and microscopic

spTenic foTTicTes (3).
Chronic Toxicity

Horn, gt_al., (6) fed citric acid to rats at TeveTs of 1.2 and 2.0 g/kg
body weight for 2 years.

SurvivaT rates were not affected, but treated

animaTs grew more siowTy than controTs.

After 2 years, organ weights were not

affected and no histopathoTogicaT changes were seen in thyroid, Tung, heart,
Tiver, spTeen, kidney, adrenaT, stomach, smaTT and Targe intestine, pancreas,
bone marrow or testicuTar tissue.
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Rats fed diets containing 1.2% citric acid (daily intake 0.8 g/kg) showed
no harmful effects with respect to growth in 2 successive generations over a
90 week period.

No reproductive effects were noted, nor were significant

changes noted in hematology or histopathology (4).
Carcinogenicity

No carcinogenicity bioassay has been carried out on citric acid or its
salts.

If citrate was carcinogenic to rats, one would have expected

significant histopathological changes in the chronic studies since such high
doses were

utilized (4,6).

Mutagenicity

Citric acid, potassium and sodium citrate have

been studied in a variety

of systems, both microbial and mammalian, with and without metabolic

activation.

Microbial tests in Salmonella typhimurium (strains TA-1535, 1537

and 1538) and Saccharomyces cerevisiae, Du were negative for sodium and
potassium citrate.

Citric acid was found to be non-mutagenic in a host-mediated assay using
§L typhimurium TA-153O and 6-46, and §; cerevisiae D3. Doses up to
3.5 g/kg body weight were utilized. Citric acid given orally to rats at 3 g/kg/day

for 5 days did not produce significant chromosome aberrations. Similarly, at
0.6 mg/mL of media, citric acid did not produce significant chromosome aber-

rations in human embryo lung cells (WI 38).

Citric acid was also found to be

negative in the dominant lethal assay in rats at doses of 3 g/kg/day for 5 days (3).

Teratogenicity

rats,
The teratogenic potential of citric acid has been studied in mice,
hamsters, and rabbits by administration of doses between 241 - 425 mg/kg
during the period of organogenesis. No adverse effects on oval implantation,
maternal or fetal survival were noted.

The number of abnormalities seen in

(3).
either soft or skeletal tissues did not differ in control of treated animals

29

Summary

No evidence exists to indicate man's present daily intake of approximately
4.5 g of citrate poses a health hazard.

Even if citrates were used at the

level of 25% in all detergents (highly unlikely), man's daily intake would
increase by less than 0.001% (0.4 mg/day).

The World Health Organization (4)

indicated that an acceptable daily intake for citrates was "not limited".

The

use of citrates in detergents poses no hazard to man.
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6.PHOSPHATES*
LQECQQQEELOQ '
Phosphorus is an element essential to all forms of life, both animal and
plant. Phosphorus is present in water as orthophosphate, and in soils as
soluble orthophosphate and the insoluble apatite form. Enough C02 is
present in soil water, in equilibrium with the 602 in the air, to create
slightly acidic conditions, and thus permit continuing solubilization of the
apatite to the orthophosphate form that can be utilized by organisms (1).
Many other chemical forms of phosphorus anion exist; the relevant ones are
discussed below.
Phosphate-transfer reactions are vital to energy transfer and to the
metabolism of lipid, protein and carbohydrate.

part of the nucleic acid structure.

Phosphate is also an essential

Phosphorus is a major component of the

body, predominantly in the bones and teeth.

The blood serum levels of

phosphorus in adults are usually in the 2.5-4.5mg/100mL range (1, 2, 3).
Phosphates have many important uses in industry and agriculture.

Salts of

various forms of phosphate have been used extensively in detergents and
cleaning agents for many years.

In detergents the condensed and polymeric

phosphate salts function as detergency builders while the salts of

orthophosphate provide alkalinity and emulsifying action (4).

Approximately

95% of the phosphate used as detergent builder is sodium tripolyphosphate,
NasP301o, and most of the rest is tetrapotassium pyrophosphate, K9P207,
and tetrasodium pyrophosphate, NawP207 (5).

Trisodium orthophosphate, NaaPOu,

has been used in heavy duty cleaning compounds or, in the dodecahydrate form,
is sold as such for that purpose (4).
There have been three general reviews relating to the safety of phosphates

to humans.
*

A 1978 review (5) by the FMC Corporation, Monsanto, Olin and

Contributed by R.D. O'Brien

Procter & Gamble deals specifically with detergent phosphates, their
chemistry, industrial production methods and amounts
water and sewage.

and levels achieved in

The Food and Drug Administration reviewed in 1975 (3) the

health effects of phosphates in foods.

The National Academy of Sciences

surveyed (6) in 1972 the extent of use of phosphate and other food chemicals
"generally recognized as safe.
Levels

Since no known organisms can synthesize the phosphate anion, it has to be
absorbed through the food supply.
in phosphorus.

Animal and cereal products are quite high

For example, in approximate figures, cheddar cheese has 524

mg/lOOg, oatmeal 395mg/100g, eggs 224mg/1009, lean beef 240mg/100g.

Plant

products have considerably less--lettuce 28mg/1009, potatoes 56mg/100g,

oranges 21mg/1009 (2).
It has been estimated that the total food supplies in the United Kingdom

provide about 1500mg of phosphorus per person per day (7).

The 1972 NAS study

(6) estimated the average U.S. intake of phosphorus was 300mg per day, with
one third as calcium phosphates.

The Food and Nutrition Board of the National

Research Council (USA) recommends a dietary allowance of 800mg of phosphorus
per day.
We now consider phosphorus intake from water.

The total phosphorus

content in waters can be divided into that which is available and that which
is unavailable for biological assimilation.

Part of the phosphorus associated

with any soil particle may be chemically or physically bound to the particle
and therefore unavailable.

Based on river mouth data, the total phosphorus

load in the Great Lakes (presumably in the absence of detergent contribution)

consists of a soluble fraction and a particulate fraction.

The soluble

fraction is essentially all readily available, but only a portion of the
particulate fraction is available.
The average contribution of household cleaners to the total phosphorus

load in domestic sewage was about 53% in 1969 and had been reduced to 38% by
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1976 (5).

Other major contributors of phosphorus to receiving waters in
addition to households are the non-point sources which include agricultural,
forest and urban runoff and atmospheric sources. The phosphorus contribution
from detergents flowing into the Great Lakes is 10% of the total phosphorus
load to the Lakes.

Another calculation, by the detergent manufacturers (5), was based on a
"worst-case scenario in which there was no phosphorus removal at municipal
sewage treatment plants, and only a hundred-fold dilution of the phosphorus
prior to discharge into receiving waters; the calculation also assumed that
phosphates made up 20% of detergents, which is no longer the case.

This

calculation showed 0.023mg of detergent phosphorus per litre as the averaged
value of phosphorus contribution to surface waters; local concentration could
of course vary substantially.
If the above calculations are correct, an individual drinking two litres
of water a day would take in 0.046mg of available phosphorus from detergent,
and about half as much from other sources.

Another more specific calculation

from the same source computed in the case of Lake Erie is an intake of 0.008mg
per day derived from detergent.

Either amount is small compared with the

300mg of phosphorus estimated above as the intake in the U.S.A. from food
sources.
Acute Toxicity

The detergent phosphates are categorized as having slight to moderate
acute toxicity (8).

Massive ingestion of phosphoric acid and its salts

results in acidosis and hypocalcemia.

Oral doses to produce death are very

large, e.g. the LDso (the dose lethal to 50% of the animals) of monobasic
sodium phosphate for the guinea pig is over 449mg of phosphorus per kg of body

weight (3). The acute oral LDso of pentasodium tripolyphosphate in mice
is 811mg of phosphorus per kg of body weight (2). The acute oral LDso for
rats of sodium tripolyphosphate is 6.509/kg; of tetrasodium pyrophosphate,

4-009/kg; of trisodium orthophosphate dodecahydrate, 7.40g/kg (9).

Comparable

published acute toxicity data on potassium phosphates are not available, but

l

33

l

I i

they are expected to be more toxic than the corresponding sodium salts due to
the inherently greater toxicity of potassium (8).

The types of detergents

that contain phosphate builders, i.e. laundry detergents, automatic dishwasher
detergents, and hard surface cleaners and cleansers, are of low toxicity

having acute oral LDso's for rats of 3 to l3g/kg (10).
These levels for acute toxicity can be compared with the above data on

human intakes, recalculated on a body weight basis and assuming a body weight
of 70kg. The phosphorus intake from food (using the U.S. value of 300mg per
day) would be 4mg/kg, or about one hundredth of the guinea pig oral LDso.
The intake from water, assuming a quantity of 0.075mg daily (which includes
potential detergent), would be 0.001mg/kg, which is less than the guinea pig
oral L050 by a factor of 450,000.

Weaver and Griffith (11) have shown that sodium tripolyphosphate, granular
detergents that contain 50 60% of this builder, and potassium pyrophosphate
are potent, prompt acting emetics when given orally to beagles. As induction

of vomiting is widely used as a first aid measure in product ingestion, these
authors suggested that the emetic action of the phosphate builders provides a
safety factor in preventing the retention of detergent in the stomach.
Gosselin, gt al., (8) confirm that nausea and vomiting, and diarrhea as well,
are probable after ingestion of tripolyphosphate or pyrophosphates. These
phosphates are thought to be hydrolyzed to orthophosphate before absorption.
If appreciable amounts of complex phosphate are absorbed, there may be binding
of ionized serum calcium with a danger of hypocalcemic tetany. One such

episode apparently occurred in a case involving a water softener.

Trisodium orthophosphate or TSP, which has been sold in the dodecahydrate
form as a cleaning agent, forms strongly alkaline solutions in water and is
reported to have produced injuries on ingestion similar to those caused by
lye (8).

As for other routes of entry, there is an example of acute orthophosphate
toxicity in which a 2 1/2 year old girl developed marked hyperphosphatemia,
hypernatremia, hypocalcemia and acidosis after two pediatric sodium dihydrogen
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phosphate enemas of 67.5mL each which contained 3.79 of
phosphorus (12).

Symptoms started to appear after 90 minutes and were reliev
ed with the
administration of calcium gluconate.

0n the other hand, several thousand cases of accidental ingest
ion of
detergents by children occur annually in the United States (13).
Many of the
products involved contain phosphates, and follow-up studies confirm
that

complications (other than nausea, vomiting, or diarrhea) rarely occur (14).

Topical exposure of skin and eyes to phosphate builders usually occurs
in
the context of handling or using the detergent products that contain them.

Thus most reports of testing involve formulated products.

However, Nixon, et

31., (15) reported that 50% aqueous sodium tripolyphosphate caused negligible
irritation to intact skin of rabbits, guinea pigs, or humans in four-hour
patch test exposures. Under the same test conditions, guinea pig and rabbit
skin showed slight and moderate irritation, respectively, from a detergent
product that contained 50% sodium tripolyphosphate, which suggests that the
ingredients other than the phosphate were more likely the source of
irritation.

Human skin showed negligible irritation from the detergent.

A battery of skin and eye irritancy tests on animals or human subjects was
used on two detergents that contained 50% "condensed phosphate" (sodium

tripolyphosphate) to assess effects on skin and eyes (16).

Another study (17)

involved similar products that also contained proteolytic enzymes.
studies showed mild irritant effects from the products.

Both

Predictive, repeated

application patch tests for skin sensitization involved 2055 human subjects in
the first series and 1478 in the second.

There was no evidence of skin

sensitization, thus sodium tripolyphosphate apears to have no allergenic
propensities.
Subchronic Studies

Many studies have been done to investigate the short-term effects of
phosphates added to the diets of experimental animals.

One of the signs

indicating a phOSphate overdose is the occurrence of metastatic calcium in the
kidney, stomach and aorta.

Resorption of bone is also characteristic.
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Male rats fed diets containing either 8% metaphosphate or 8% sodium

orthophosphate for seven months or until death showed increas
ed urinary

excretion of inorganic phosphorus, enlarged parathyroids (2
to 8 times that of
controls), and calcium deposits in the tubules of the outer medull
a of the

kidney (18).

Calcification occurs in the area of the Loop of Henle and the

terminal part of the proximal tubule.

Hodge carried out short-term feeding studies with rats and dogs of
sodium
tripolyphosphate, sodium trimetaphosphate, sodium tetrametaphosphate
, and

sodium hexametaphosphate (19). The studies were designed to
detect and assess
renal damage in view of reported harmful effects of large amount
s of
orthophosphate on the kidney. Weanling rats were fed diets
for one month that
contained 0.2, 2.0, or 10% of the test phosphate. Control rats
received basal
diet alone, or supplemented with 10% sodium chloride or 5% sodium
orthophosphate. Growth retardation was seen with the sodium
chloride and
sodium phosphate control rats and with the rats receiving 10%
of condensed

phosphate.

kidneys.

The latter rats also had tubular degeneration and necros
is of the

The

no-effect" level of the condensed phosphates was 2% in all
cases. Dogs fed 0.lg/kg/day of the condensed phosphates showed
no effects.
Exposure up to 5 months to from 1 to 4g/kg/day produced renal lesions
similar
to those seen in rats at 10% of the diet.
Ten female adult mongrel dogs fed diets supplemented with potass
ium
phosphate at 2.89 phosphorus/day for four months and then 3.lg/d
ay for six
months showed multiple microscopic areas of calcification
in the kidney
medulla, decreased urinary calcium excretion, increased
urinary phosphate
excretion,

increased bone resorption.

calcium deposits in their eye lenses.

Eight out of the ten dogs developed

In five of these eight, the calcium

deposits were associated with changes compatible with
cataracts (20).

If the levels fed to dogs in the above experiments had
comparable effects
in humans, and if we assume the dogs weighed 7kg and the
humans 70kg, then the
daily amounts that showed undesirable effects were equiva
lent to 30,000mg of
phosphorus per human, which is 100 times the U.S. intake
in food and 400,000
times the intake in water.
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Chronic Studies

There are two relevant long term feeding studies of condensed phosphates

used in detergents.

Hodge fed groups of 50 weanling male and female rats for

24 months with laboratory chow diets containing zero, 0.05, 0.5, or 5% sodium

tripolyphosphate (19).

The added phosphorus equivalents were 0.012, 0.125,

and 1.25%; FASEB estimated that the highest level was equivalent to 630mg of
phosphorus added per kg of body weight (3).

0n the basis of growth, food

consumption, hematology, urine analysis, mortality, organ weights, and
histopathology, 0.05 and 0.5% sodium tripolyphosphate were no effect levels.

The high level produced greatly increased kidney weight and size in males,
accompanied by dilated convoluted tubules, interstitial and glomerular

fibrosis and intertubular calcification.
In the second study, two detergents containing 50% condensed phosphate
(sodium tripolyphosphate) were added to laboratory chow diets of separate
groups of 40 male and 40 female rats each for two years at levels of

phosphorus equivalent to 0.063% (21). There were no toxic effects to test
animals compared with control animals that received the basal diet.

of phosphorus
If the highest no effect level in these two studies, 63mg
t-case human intake of
added per kg of body weight, is compared with the "wors
mg phosphorus (in 2
detergent derived phosphorus in drinking water of 0.046
is a safety factor of more
litres of water per day) for a 50kg adult, there
than 68,000.

Carcinogenicity and Mutagenicity

by Hodge (19) and Snyder, £3
In feeding studies of sodium tripolyphosphate
5% in the first case and at 0.25%
31., (21), rats fed diets containing up to
titative change from the normal
in the second showed no qualitative or quan
ls.
incidence of tumors found in control anima

um acid pyrophosphate was
No evidence of mutagenic effects for sodi
host mediated assay in mice using
obtained in a study that included: (a)
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Salmonella typhimurium TA1530 and mitotic recombination frequency in
Saccharomyces cerevisiae D3; (b) in 11:39 mutagenic assay with S; typhimurium
strains TA1535, TA1536, TA1537, and TA1538 in the presence and absence of
metabolic activation; (c) dominant lethal test in rats; and (d) translocation
test in mice (3).
Teratogenicity and Reproductive Effects

Sodium tripolyphosphate was embryotoxic but not teratogenic in avian
embryos at levels up to 32mg of phosphorus per kg of egg. Sodium
tripolyphosphate was given on day 6 through day 15 of gestation to pregnant
mice (up to 60mg/kg as phosphorus), pregnant rats (up to 43mg/kg as
phosphorus), pregnant hamsters from day 6 to day 10 (up to 36mg/kg as
phosphorus), and pregnant rabbits from day 6 through day 18 (up to 63 mg/kg as
phosphorus). No effects on oval implantation or maternal or fetal survival
were seen. There was no significant increase in the number of abnormalities

in soft or skeletal tissue (3).

Sodium tripolyphosphate, sodium trimetaphosphate, or sodium hexameta
phosphate had no effect on fertility or litter size nor on growth or survival

of offspring in reproduction studies with three generations of rats maintained
on diets containing 0.5% of condensed phosphate (19).
Conclusions

The amount of phosphorus contributed by detergents to human intake is in
the range of 0.01 to 0.1mg per person per day, and is therefore exceptionally
small compared with the estimated U.S. food intake of 300mg per person per day.

Two lines of evidence suggest that detergent phosphorus derived through
drinking water poses no health hazard. One is that, in comparison with the

above human intakes, enormously larger amounts, by factors of several hundred
thousand, are needed to produce detectable toxic effects (acute, subchronic
or
chronic) in laboratory animals and even these very large quantities are not
carcinogenic, mutagenic, or teratogenic.
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A second Iine of evidence is that a 1975 review (3) for the Food and Drug
Administration of heaIth aspects of phosphates in foods showed that there was
no hazard from the 300mg of phosphorus taken in dain by humans in food;

indeed Such Iarge amounts are essentiaI for heaIth.

These food intakes of

phosphorus are 6,000 times greater than water intakes, even under a
"worst-case" scenario.

Phosphorus occurs in numerous forms; a1] the 23 forms

which have any significant representation in food and these incIude the forms

found in detergents and naturai water, were specificaIIy exonerated from any
hazards when used at current Ieveis.

In December 1979 the Food and Drug

Administration proposed to affirm that such phosphates shouId be generaiiy
regarded as safe for addition to food.

They exempted caicium hexameta-

phosphate and potassium ponmetaphosphate from this status because they were

not normaIIy used as food additives (22).
It is conciuded that phosphates used as detergent builders do not pose a
heaIth hazard through their contribution of phosphorus to drinking water.
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7. SOLUBLE SILICATES*

Introduction

Soluble silicates possess utility in a spectrum of applications including
food packaging, medical products, the treatment of drinking water and in high
phosphate, reduced phosphate and non-phosphate detergents.
The Select Committee of the Federation of American Societies for
Experimental Biology (FASEB, 1979) in a final evaluation for the U.S. Food and
Drug Administration of the health aspects of certain silicates as food
ingredients, concluded that sodium silicate, sodium aluminosilicate, calcium

aluminosilicate, calcium silicate, magnesium silicate, potassium silicate,
tricalcium silicate, silica aerogel and talc do not present a hazard to the
public under current use.

It should be recognized that this conclusion was in basic agreement with
an earlier FAG/WHO (1974) toxicological evaluation which established no limit
for the acceptable daily intake of the above silicates with the exception of
magnesium silicate and talc.

The principal objective of this report is to review the available
literature on the toxicity of the soluble silicates with a primary focus on
sodium silicate. It is, however, useful to initially review the germane

aspects of the chemistry, use patterns and environmental aspects of the
soluble silicates.

Chemistry, Use Patterns and Environmental Aspects

high alkaline
The soluble silicates cover a range of compositions. 0n the
icate
side, species are stoichiometric and crystalline, 9.9., sodium metasil

*

Contributed by L. Fishbein
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(Na25i03).
metric.

0n the high silica side, commercial materials are non stoichio-

These are available as viscous solutions or as amorphous solids.

They are specified in terms of their weight ratios of Si02/Na20.

Sodium

silicate, ranging from 2.0 to 2.5 SiOz/Na20, is most frequently used in
laundry detergents (Sturm, §t_al, 1978).
now obsolete.

The colloquial term "waterglass" is

It had been applied to viscous sodium silicate solutions of

about 3.3 SiOZ/Nazo as used for egg preserving (Wills, 1969).
As a detergent builder sodium silicate plays several roles, depending on
the function and composition of the detergent.

For example, in phosphate-

built detergents, sodium silicate maintains soil particles in suspension and
is not a water softener.

In contrast, in the carbonate/silicate builder

combination, the silicate buffers the solution at an alkaline pH where calcium
carbonate and magnesium hydroxide precipitate most effectively.

The silicate

may sequester magnesium in carbonate and zeolite-built detergents.
Additionally, sodium silicate also deflocculates particulate soil, emulsifies
and saponifies greasy oil, absorbs liquid detergent ingredients, provides
crisp, free-flowing granules when spray dried and may also inhibit the
corrosion of metal in the washing machine (Sturm, §t_gl., 1978).
The levels of sodium silicate (Na20-25i0)2 in detergent based on various

use patterns are as follows (Sturm, gt_gl., 1978):
use:

(1) based on historical

5%; (2) based on current use in reduced phosphate detergent:

based on possible use in non-phosphate detergent:

20%.

10%; (3)

At concentrations

below 120 ppm, the only stable species in aqueous solution is monomeric and is

indistinguishable from naturally dissolved silica (Sturm, 33 al., 1978; Stumm,
1970).
Sodium silicate (at a concentration of 8 mg/L Si02) is added to
municipal and domestic water supplies to inhibit the corrosion of pipes, pumps

and tanks (Sturm, et al., 1978).
It is important to note that silica, silicic acid and the calcium,
magnesium and aluminum salts are ubiquitous in the environment and hence it
can be considered unlikely that man can avoid silicon exposure.
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At least 25%

of the earth's crust is composed of silicon in the form of
silicon dioxide

(sand and quartz) and the salts of silicic acid (FASEB, 1979).

Silicon is found in all natural waters (Krauskopf, 1967). Ground
waters
contain the highest concentrations of natural silica. Streams and rivers
contain more dissolved silica than do the lakes and oceans.

For example, the

worldwide concentration of silica is 13.1 mg/L while that of the Great Lakes,

is about 4 mg/L (Sturm, gt_al., 1978).

Silica levels found in surface waters

as a result of detergent use (at the 20% level) are of the order of 0.064 mg/L
(6.4 mg/L raw sewage, assuming a sewage effluent dilution of 1:100) (Sturm, et

21., 1978).

A survey of the mineral content of finished water in public water supplies
of 100 largest U.S. cities in 1962 indicated that the median, high and low
concentrations of silica were 7.1, 7.2 and 0.07 mg/L respectively (Durfor and
Becker, 1964).
Silicon is found in almost all terrestrial and aquatic organisms (Allison,
1968).

In humans, the lungs and peribronchial lymph nodes have the highest

silica content, 14-2000 mg/lOOg and 27-5000 mg/lOOg respectively (King and
Belt, 1938).

The silica content of these tissues increases with age and this

has been suggested to be due primarily to the continual inhalation of house
and street dust.

In contrast there is a constant low concentration in other

organs and muscle that does not appear to vary with time (e.g., psoas muscle
and kidney concentrations are of the order of 23/100 mg/lOOg and 11-27 mg/lOOg

respectively) (King and Belt, 1938).
It should be additionally noted that foods contain naturally occurring

silicates.

For example, levels of silicon (in the form of silicon dioxide) in

raw potatoes are about 10.1 mg/kg, in milk 2.1 mg/L and in beer 131 mg/L
(FASEB, 1979).

Silica compounds used in food packaging include silicon

dioxides, sodium silicate and talc.

The estimated possible intake of sodium

aluminosilicate, the principal silicate food additive, is about 0.8 mg/kg/day
(FASEB, 1979).

An additional human intake of silicon can arise from its
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medicinal applications.

For example, magnesium trisilicate is used as an

antacid in the treatment of hyperchlorhydria as found in peptic ulcers and
gastritis.
Although the function of silica in the body is not definitively known,
studies with chicks (Carlisle, 1972), rats (Levier, 1975; Schwarz and Milne,
1972) and monkeys (Levier, 1975) suggest that silica may play a role in the
calcification process in bones.
Toxicity

Since sodium silicate occurs naturally and has been used in home laundry
products in the United States and United Kingdom for approximately 120 and 150
years, respectively, few formal toxicity studies exist relating to sodium

silicate per se or in any soap and/or detergent formulation.
a.

Acute Toxicity

The signs observed during eye, skin, esophageal and oral toxicity tests
included conjunctivitis, erythema, small blisters on skin, burns in oral and
alimentary canal, nausea and vomiting (International Tech. Inform. Inst.).
The acute oral LDso for sodium
glass") is 1100 mg/kg.

silicate (NaZO-nSiOZ x H20, n = 3.25, "water

The oral LDso for sodium silicate (silicic acid

disodium salt) is 1280 mg/kg in the rate (NIOSH, 1975; Philadelphia Quartz
00., 1961).

The oral L050 for sodium silicate (3.0 SiOz/Nazo) in the rat is

1600 mg/kg.

(NIOSH, 1975; Soap and Detergent Association, 1972).

In man, the estimated oral lethal doses are:

>1Sg/kg for silica

(silicon dioxide) and magnesium trisilicate and between 0.5 and 5g/kg for
sodium silicate and in the latter case, may well be due to the compound's
alkalinity (Anon, 1964; FAD/WHO, 1974).
The intraperitoneal LDLo for sodium silicate (designated water glass)

in the guinea pig is 200 mg/kg (NIOSH, 1975).

The minimal lethal i.v. dose of

sodium metasilicate (NaZSi03-9H20) for rabbits is 175 mg/kg.
110 and 172.5 mg/kg caused anemia.

Doses between

Sodium silicate at levels of 20.28-55.9%

was eliminated in the urine within 11-48 hours (Gajatto, 1951).
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In a comprehensive recent study of the rate and extent
of urinary

excretion in rats after oral administration of magnesium trisili
cate,

food-grade sodium aluminosilicate and Zeolite Type A administered in doses of
0, 40, 200 or 1000 mg/kg, and sodium silicate in doses of 40
and 1000 mg/kg,
it was found that urinary silicon excretion increased rapidly after dosing and

peak excretion rates occurred within 24 hours in all test groups (Benke and

Osborne, 1979).

Zeolite A had the most rapid urinary excretion rate

(half-life, 6-8 hr).

The half-lives of magnesium trisilicate, sodium silicate

and food grade sodium aluminosilicate were 16-20 hr, 24 hr and 38 hr,
respectively. When expressed as a percentage of dose, the total urinary
silicon excreted was roughly equal for magnesium trisilicate, sodium silicate
and Zeolite A but considerably less for food grade sodium aluminosilicate*.
For all four test materials urinary silicon excretion increased with dose
level.

However,

it should be noted that the magnitude of this increase (two

to eightfold) was not as great as the increase in the amount dosed (25-fold).
The observation that the percentage of silicon excreted decreased as the dose

was increased suggested that some process in the absorption or excretion was
becoming saturated.

Similar findings were reported by King, gt_al., (1933)

who administered silicic acid to dogs and found that increasing the dose
caused a smaller fraction of the silicon to be excreted in urine. Comparable
data in humans is limited and appears to be available only for magnesium
trisilicate (Page, £3 31., 1941).

When administered to volunteers at a dose

level of 35 mg/kg/day for 4 days and the urine is collected for 48 hrs after
the last dose, the total excess silicon recovered in urine averaged 5.2%.

It

was noted by Benke and Osborn (1979) that although the data of Page, gt al.,
(1941) were not directly comparable to the single-dose data reported above in
the rat, it would appear that man absorbs less silicon from magnesium
trisilicate than does the rat.

The hazards of ingested silicates are believed

to be generally limited to effects on the kidney and bladder (Emerick, gt_al.,
1963; Tracor-Jitco, 1973).
In man, except for non-specific irritation or corrosion of skin, cornea
and mucous membranes, no apparently

toxic actions of sodium metasilicate are

recognized (Gleason, £3 31., 1968; Sax, 1968; Mills, 1969).

*Unlike Zeolite A, food grade sodium aluminosilicate is amorphous and differs
i

.
.
. .
n its Al/Si ratio
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b.

Subchronic Toxicity

There may be species related susceptibility to renal damage from ingestion
of sodium silicate.

When 15 rats of both sexes of the Charles River CD strain

were fed sodium silicate (no specified composition) at levels of 2.4 gm/kg/day
in a semi-synthetic diet for 4 weeks, the only clinical symptoms observed were
polydipsia, polyurea, and soft stools observed in a few animals.

No compound-

related lesions were found and all clinical chemical tests were within normal
limits (Newberne and Wilson, 1970).
Pure-bred beagles of both sexes about 6 months of age were fed 2.4g/kg/day
of sodium silicate in a semi-synthetic diet for 4 weeks (equivalent to

0.89/kg/day of silicon dioxide as the end product).

Gross cortical lesions of

the kidney were observed in 8/8 male dogs and in 7/8 female dogs.

The lesions

appeared to be focal, subcapsular hemorrhages and on the cut surface the

lesions suggested cortical infarcts (Newberne and Wilson, 1970).

Although the

nature of the lesion was the same in all cases, the severity varied from one
animal to another, and from one area to another within the kidney.
Hypertrophy of tubular epithelium, with or without degenerative changes,
inflammatory cell infiltration into the interstitium, and dilatation of some
and collapse of other tubular epithelium were all observed to varying degrees
within localized areas of the kidney.

The general impression was one of

irritation of tubular epithelium followed by degenerative and regenerative
changes.

These alterations were accompanied by inflammatory cell infiltration

into the interstitium.

Although there was presence of extensive renal damage,

impairment of renal function was not detected by any of the clinical tests
conducted on serum or urine.

It should be noted that magnesium trisilicate

administered to dogs at 1.8g/kg/day (also equivalent to 0.89/kg/day of silicon
dioxide) for 4 weeks produced the same lesions.

It was speculated that both

sodium silicate and magnesium trisilicate were apparently absorbed from the
gut and damaged the kidney as they or their metabolic products were excreted
in the urine (Newberne and Wilson, 1970).
Settle and Sauer (1960) earlier reported that siliceous deposits formed in
the kidneys of guinea pigs given large dose of soluble silica orally or
intraperitoneally.
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c.

Chronic Toxicity and Carcinogenicity

There are no apparent reports in the literature of chronic testing or

carcinogenicity of sodium silicate in any form.
d.

Mutagenicity

Sodium silicate was not mutagenic when tested with E; co i (Demerec, gt
al., 1951).
e.

Teratogenicity

There are no existing teratogenicity data on sodium silicates.
f.

Epidemiology

There have been no epidemiological studies related to sodium silicate

per se.

Endemic Balkan nephropathy (BN) including marked kidney fibrosis has

been associated with a long period of human consumption of drinking water
believed by some to be contaminated by silicates (Markovic, 1972a,b; Markovic

and Arambasic, 1971).

However, it should be noted that other suggested

etiologic agents have included plant and fungal toxins, viruses, lead and
uranium (Austwick, 1975; Barnes, et_al., 1977; Georgescu, 1976; Krogh and

Elling, 1976; Sattler, et a1, 1977).

It was suggested (Markovic, 1972a,b;

Marcovic and Arambasic, 1971) that these silicates decomposed in the body

after ingestion, releasing silicic acid which was excreted in concentrated

form by the kidneys and appeared to be the cause of the fibrosis. It was
believed that malignant tumors of the urinary tract found in approximately

one-third of those autopsied in Yugoslavia was related to heavy and
radioactive metals present with the silicates and released during their

decomposition in the body (Markovic, 1972a,b).

s in
A study of Benninger, gt al., (1974) failed to produce renal change
the guinea pig by chronic administration of silicic acid. The authors
suggested that since silicic acid was not nephrotoxic, silicates in the
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drinking water are not of primary significance in the pathogenesis of endemic
Balkan nephropathy as has been previously proposed (Markovic, 1972a,b;
Markovic and Arambasic, 1971).
All sodium silicate species, whether of natural or synthetic origin, lead
to the same monomeric silica in solution.

Above the solubility limit for

monomeric silica, which is pH-dependent, oligomeric and finally polymeric
silica form.

These processes are the same internally as elsewhere in nature

(Stumm, 1970; FASEB, 1979).
g.

Metabolism

After ingestion, silicates have been reported to be decomposed in humans
to silicic acid which is excreted in concentrated form by the kidneys

(Markovic, 1972a,b).

It has been postulated that when a silicate (e.g.,

magnesium trisilicate) is ingested or administered, part of the silica so
formed is precipitated as a gel and part remains in solution.
Silicic acid has been reported to be a normal constituent of human urine.
the amount excreted is in the range of 10-30 mg/day depending on the diet.
Ingested silicic acid rapidly penetrates the intestine and is distributed
throughout the extracellular fluid.
at levels below 1 pg SiOz/cms.

Silicic acid has also been found in blood

It has not been found to bind to protein or to

other large macromolecules (FAG/WHO, 1974).
Previous Evaluations and Summary

The FAO/WHO (1974) toxicological evaluation of silicon dioxide and certain
silicates in relation to food additives concluded that with the exception of

the reported damage to dog kidney by sodium silicate and magnesium
trisilicate, any silicate absorbed is excreted by the kidneys without evidence
of toxic cumulation in the body.

The available data on orally administered

silica and silicates appeared to substantiate the biological inertness of
these compounds.
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As noted previously in this report, FASEB (1979) in a review
and
evaluation of the health aspects of certain silicates as food ingredients for
the U.S. Food and Drug Administration concluded that sodium silicate (as well
as aluminum calcium silicate, calcium silicate, magnesium silicate, potassium
silicate, sodium aluminosilicate, tricalcium silicate, silica aerogel and

talc) do not present a hazard to the public under current use. The
"unpublished GRAS status of sodium silicate for direct use in food should

also be noted (SCOGS-61 report, FASEB, 1979).
The U.S. Public Health Service has also stated that "the use of small
amounts of sodium silicate added to drinking water would, as far as is known,
produce no ill-effects upon the users of the water" (Vail, 1952).
Conclusion

It is concluded that the use of sodium silicate in detergents poses no
hazard to man.

5l
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8. ALUMINOSILICATES (TYPE A SODIUM ZEOLITE)*

Introduction

Aluminosilicates have a variety of uses, including the food industry.
Food grade aluminosilicate is approved for use in certain foods up to levels
of 2 percent. Aluminosilicates, aluminum compounds and silicates are widely
used in the treatment of drinking water.

Recently, the Federation of American Societies for Experimental Biology
completed a review and evaluation of the health aspects of certain silicates
as food ingredients for the United States Food and Drug Administration.

(1)

The conclusion of the committee was that aluminum calcium silicate, calcium
silicate, magnesium silicate, potassium silicate, sodium silicate, sodium

aluminosilicate, tricalcium silicate and silica aerogel, do not present a
hazard to the public under current use.

This conclusion was in agreement with

earlier decisions by the World Health Organization (WHO) and the Food and
Agriculture
Organization(FAO), which established no limit for the acceptable
daily intake of these same silicates, with the exception of magnesium silicate.
This report concerns the health aspects of synthetic Type A Zeolite

(sodium aluminosilicate) utilized in household detergents.

A review of the

chemical and toxicological data on this aluminosilicate (2,3,4) will be made

to ascertain whether the potential health risk is markedly different from
other widely used silicon compounds (e.g. sodium silicate, sodium

aluminosilicate, etc.).
Chemistry and Environmental Levels

A knowledge of the chemistry of Type A Zeolite is essential for proper
evaluation of the results from toxicological experiments.

*

Contributed by G.C. Becking
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It is a synthetic, crystalline, inorganic sodium
aluminosilicate, having a
Na:Al:Si ratio of 1:1:1, and is cubic in structure.
Type A Zeolite is more
thermodynamically unstable than food grade aluminosil
icate, which has a
Na:Al:Si ratio of 1:1:13. In aqueous suspensions,
it will transform to
amorphous aluminates (clay-like materials) and sodiu
m silicates. The presence
of protons or chelators in the environment will enhan
ce the removal of

silicates from the cuboidal structure, destroying
the rigid cubic structure.

At pH <5 the transformation takes place in a few secon
ds, and at pH values
between 5 and 8, the rate is fast, but may take a few
minutes to complete.
a pH above 8 the same transformation occurs but at
a slower rate.

At

Given this instability, cuboidal Type A Zeolite will
rarely be found in
the environment. It will rapidly transform to amorp
hous aluminates and
soluble silicates under the acid conditions of the
stomach and the neutral
conditions of other tissues and the general environmen
t. Both transformation
products have an extensive history of safe usage.
In the United States, the median levels of
soluble silicate (measured as

SlOz) and soluble aluminate (measured as Al) are 7.1 mg/L
and 0.054 mg/L

respectively.

Assuming an exaggerated use pattern, that is, where
all
detergents were built with 20 percent Type A Zeoli
te, environmental studies
showed that transformation products would result in
0.00003 mg/L Al/L and
0.00007 mg/L Si02 in potable water. These findings
have been confirmed in
both laboratory and pilot scale studies of drinking
water treatment processes
and conditions. No particles resembling the cuboi
dal structure of Type A
Zeolite have been found in these studies.

&

Acute Toxicity

Extensive acute toxicity studies on Type A Zeoli
te indicate that this
material is an acutely nontoxic chemical (5).
It is non-toxic when ingested
in a single dose and is relatively non-irritating
to the eye and skin. Type A
Zeolite does not produce sensitization and is non
irritating to the
respiratory system after a single inhalation
exposure. The studies on which
the above conclusions were made are summarized
in Table l.

k

TABLE 1

ACUTE ORAL, DERMAL, OCULAR, AND INHALATI
ON STUDIES
Test

Oral

Results

>27.0 g/kg; no lethality at 27 g/kg

LDso

Oral toxicity (Dog)

1 g/kg produced slight hyperemia of stomach

Eye irritation (Rabbit)
3 mg unrinsed
3 mg rinsed
0.1 mL of 10% aqueous

Non-irritating

Eye irritation (Monkey)

Slight irritation which subsided within
48 hours

35 mg unrinsed

Rin irritation (Rabbit)

Abraded and Non Abraded
Slightly moistened; 20% aqueous
slurry Zeolite A 24-hour,
closed patch

Mild irritation consisting of mild erythema

win irritation (Human)
Single patch, 50% aqueous slurry

Mute Percutaneous Toxicity (
Abraded and Non abraded

Non-irritating

Rabbit)

No deaths; mild erythema at treatment site

2 g/kg; 24 hour closed patch

knsitization (Guinea Pig)
50% aqueous slurry

(3 weekly applications and
challenge)

No sensitization

%nsitization (Humans)
5% aqueous slurry

(9 weekly applications and
challenge)

No sensitization

Mute inhalation (Rats)
Single l-hr exposure: 2.4 and

18.3 mg/L

No observable toxic effects

0.14 mg/L

No observable toxic effects

Single 4-hr exposure; 0.08 and

kute intratracheal instillation (Rats)

Irritation potential of Type A Zeolite is

m vitro (Rabbits) and in vivo (Rats and

Toxicity rating: TYPE A Zeolite<Clay<Quartz

similar to calcium carbonate and less than
silica flour

Hamsters) alveolar macrophage
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Metabolism and Subchronic Toxicity Studies

Both acute and sub-chronic metabolic studies
have been conducted on Type A
Zeolite in rat, monkey and man to determine its
absorption, distribution and
excretion pattern. Additionally, reactions to Type
A Zeolite in a model human
stomach were studied, as was the relationship
between the concentration of
soluble and particulate silicon species in human
urine and the level of
silicon in potable water. A summary of the vario
us metabolic tests was

presented to the IJC Task Force by the Proct
er and Gamble Company (2,3) and is

reproduced with minor changes in Table 2.

TABLE 2
Metabolism Studies

Test

Results

Stomach Model - Human

Type A Zeolite is hydrolyzed to aluminates
and silicates

Acute (single dose)
rat and monkey: 0,40,200 or 1000 mg

- Urinary silicon markedly increased,
urinary aluminum unchanged

man:

- In man, blood Al <1 ug/mL after single
40 mg/kg dose
- Similar urinary silicon excretion (% of dowl
in all 3 species

Type A Zeolite/kg

0 or 40 mg Type A Zeolite/kg

Sub chronic in rats
0 and 2% in diet - 8 weeks

85-110% of dosed aluminum found in rat fecm'

- Increase in urinary silicon; urinary
aluminum unchanged
- No significant tissue st0rage of aluminum
- No kinetic evidence for multiple tissue
binding sites for silicon

Excretion of urinary particulate

A marked increase in excretion of particulae-

Silicon (rats); 0, 0.125, 0.25, 0.5,
1 and 2% in diet 3 - 16 weeks

Human Urinary Silicon - Excretion
in relation to drinking water
silicon levels

silicon noted at 0.125

0.25% Type A Zeol e

Drinking water silicon (median level 7 mg/U
l
does not affect urinary particulate silicon
excretion
- <1 pg/L silicon contributed to drinking
water through use of Type A Zeolite would
increase urinary excretion of soluble silica
<0.02%.
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te

Acute and sub chronic metabolic studies have been conducted with
Type A

Zeolite and other silicon containing compounds, such as sodium silicate,
magnesium trisilicate and food grade sodium aluminosilicate, which have been
approved as safe for food use by the U.S. Food and Drug Administration (FDA),
the WHO and other international agencies. The above studies indicate that
Type A Zeolite is hydrolyzed in the stomach to silicates and aluminates and
only the silicon moiety of Type A Zeolite is partially absorbed.

The acute studies show that, as the dose of Type A Zeolite is increased,
urinary silicon excretion is increased.

Aluminum is recovered in the feces.

This fecal aluminum represents unabsorbed aluminum, since analysis of bile
from animals dosed with Type A Zeolite show that bile is not a route of
excretion for Type A Zeolite.
Urinary excretion of silicon, expressed as percent of silicon dosed, was
similar for rat, monkey and man when dosed with a single large dose of Type A
Zeolite.

To this extent the rat is an appropriate model for chronic toxicity

studies on Type A Zeolite.
The sub-chronic metabolic studies conducted in rats provide additional
support for the conclusion that Type A Zeolite is hydrolyzed in the stomach to
silicates and aluminates and that only the silicon moiety of Type A Zeolite is
absorbed.

These studies show that as the dose of Type A Zeolite in the rat

diet is increased, the amount of silicon excreted in the urine is markedly
increased while urinary aluminum and tissue aluminum remain unchanged.
Urinary silicon excretion is such that at dietary concentrations greater than

0.125% Type A Zeolite, the urinary silicon burden becomes so great that the
urine becomes saturated with soluble silicate and silicate precipitation

occurs in the urine (referred to herein as "particulate" silicon).
A human urinary silicon monitoring program investigating the relationship

between natural levels of silicon in the drinking water (1-10 ppm SiOz)
and the excretion of soluble and "particulate" silicon (silicon precipitate >0.4u)

in the urine shows that drinking water containing up

to 10 ppm 5102 has no

effect on urinary "particulate" silicon excretion, thus indicating that the

61

IiIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIlllllllllllllllllllllil

parts per billion of silicon added to the drinking water throug
h the large
scale use of Type A Zeolite in the detergent industry is not likely
to cause
an increase in urinary "particulate" silicon.
The above extensive metabolic experiments in several species
, including

man, have provided ample proof that the oral toxicity of Type
A Zeolite is
that of soluble silicates.

Also, the sub-chronic feeding studies, in which

rats were fed diets containing 0.1 to 2% Type A Zeolite
for periods of time
between 90 and 200 days, indicate that Type A Zeolite is a relati
vely
non-toxic chemical. Significant toxic manifestatons were
only noted at doses

producing high levels of urinary particulate silicon.

In Cox or Long Evans rats, dietary levels of Zeolite A as
high as 2%
failed to cause dose related effects on organ weights, hemato
logy, blood
chemistry or kidney function after 168 or 200 days. Body weight
s of animals

receiving 2% Type A Zeolite were lower than controls. Also,
an increased
urine volume and decreased specific gravity were noted in
animals receiving 2%
Zeolite in the diet. Siliceous particles were noted in the
urine of all rats
receiving >0.125% Type A Zeolite in the diet. The quanti
ty of particles
appearing in the urine was dose related. Additionally,
at dietary levels
greater than 0.125% Type A Zeolite, the siliceous parti
cles aggregated to form
bladder and kidney stones. Such stones did not appear
until after 90 days on
test and the incidence of stones increased with time
and dietary levels above
0.125%. Below this "threshold" dietary level for parti
cle formation, no
compound related stones were observed. The particles
and stones were

When such changes were found particulate material

or calculi were also found. Also, after microscopi
c examination of the
kidney, ureters and urinary bladder of animals recei
ving 2% Type A Zeolite in
the diet, alterations characterized by an increase
in the incidence and
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kidney pelvic epithelium.

.

Compound related microscopic changes were observed
in the kidneys and/or
bladders of animals receiving greater than 0.125%
Type A Zeolite in the diet
for 168 or 200 days. The microscopic changes consi
sted of hyperplasia of the
transitional cell epithelium of the mucosa of the
urinary bladder and the

l-

amorphous, high in silicon content, with no detec
table aluminum.

severity of interstitial nephritis and regenerative epithe
lium were noted. No
histopathological lesions were found in animals fed diets containing 0.125%
Zeolite A. The microscopic changes appeared to be related to the urinary

silicate burden and siliceous material in the tissues. They were similar to
those reported for other silicates, such as sodium silicate, magnesium
trisilicate and silicic acid.

Twenty eight-day and 91-day dermal toxicity studies conducted in rabbits
showed that Type A Zeolite had no systemic or dermal effects. Application of
2 mL/kg bodyweight of a 10% aqueous slurry of Type A Zeolite to the backs of
rabbits 6 hr/day, 5 days per week for 4 or 13 weeks was non-irritating to the
skin and had no adverse effect on bodyweight, hematology, clinical chemistry
or histology.
Chronic Toxicity

Based on sub chronic metabolic studies and 200 day sub-chronic feeding
studies, the highest dietary dose level used in chronic studies was 0.1%.
This should be considered a maximum tolerated dose, since higher levels result
in siliceous material causing physical tissue damage.

The exact effect of

such non-physiological action on chronic toxicity is unknown.
Administration of 0.001%, 0.01% and 0.1% Type A Zeolite in the diet of
Wistar rats for 78 weeks had no compound related effects on physical

.

l-

appearance, hematology, blood chemistry or urinalysis.
Gross necropsy of animals revealed no abnormal findings.

This study

cannot be considered an adequate chronic toxicity study, but the

\_.._.__/v
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carcinogenicity bioassay (using a similar dosing regimen) utilized an
experimental design, making it a combined carcinogenicity and 104 week chronic
toxicity study.

In the carcinogenicity bioassay, results of blood chemistry, hematology,
urinalysis and body weight/food consumption studies, as well as the
histopathological examination for non cancerous lesions, support the results
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of the 78 week chronic experiment.

That is, the administration of 0.1% Type A

Zeolite in the diet for 104 weeks does not produce chronic toxicity in rats*.
No evidence of fibrosis was observed in hamsters exposed to =20 mg/m3
of Type A Zeolite, 3 days per week, 5 hours per day for 52 weeks.

The only

observation was the presence of the test material in the alveolar macrophage
and lymph nodes.
Exposure of Cynomolgus monkeys to 1 and 6 mg/m3 of Type A Zeolite or

Type A Zeolite detergent (detergent micronized to maximize inhalation) for
24 months and to 50 mg/m3 of Type A Zeolite or quartz for 12 months had no
adverse effects on bodyweight gain, hematology, serum chemistry or
urinalysis.

The only alteration in pulmonary function was a decrease in the

mean vital capacity of the monkeys exposed to quartz for 12 months.

Histopathology of the various tissues indicated that exposure to =1 and 6
mg/m3 of Type A Zeolite-containing detergents for 6 hours per day, 5 days
per week for 104 weeks produced only an increase in alveolar and septal
macrophages.

Exposure to =1 and 6 mg/m3 Type A Zeolite for 104 weeks and

=50 mg/m3 Type A Zeolite for 52 weeks produced an increase in alveolar and
septal marcrophages. In addition, at the 6 and 50 mg/m3 Type A Zeolite
doses,

sporadic inflammatory reactions were observed in the lungs of some of

the treated animals.

These inflammatory reactions were observed primarily in
lobes of the lung previously compromised by mites and kaolin. Neither Type A

Zeolite nor Type A Zeolite-containing detergents produced pulmonary fibrosis
after 104 weeks of exposure.
Compound related effects were not observed in any other tissues.

Quartz

produced progressive pulmonary fibrosis in monkeys as early as 30 weeks after
initial exposure. The observed increase in alveolar and septal macrophages
with Type A Zeolite and Type A Zeolite detergents is a classical pulmonary
clearance response to relatively innocuous, insoluble, materials deposited in
the lungs. These results support the conclusion that Type A Zeolite and Type
A Zeolite-containing detergents are relatively innocuous materials.
*

Personal Communication from the Procter and Gamble Company, regarding
information supplied to them by the Henkel Company.
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Carcinogenicity

To determine the carcinogenic potential of Type A Zeolit
e, it was
administered at 0.001, 0.01 and 0.1% in the diet of rats for
104 weeks.
the 0.1% dose there was an exacerbation of glomerulonephrosis
, a sponta

At

neous kidney disease which develops in aging rats. The 0.1% dose
is
considered a maximum tolerated dose because of the reported exacerb
ation of
this spontaneous kidney disease in female rats and because it is
the

breakpoint

which

at which there is an increase in particulate silicon in the urine
could lead to stone formation, compromising the carcinogenic assessment

in bladder and kidneys.

Tumor incidence was reported to be essentially identical among groups and
sexes whether broken down as total tumors, malignant tumors or benign tumors.

No treatment associated carcinogenicity was identifiable.

Mesenteric-lymphangiomas and pituitary tumors were the most common tumors
in males, whereas pituitary tumors were the most prevalent type of tumor in
females.

In both cases, no treatment associated or dose-response associated

carcinogenic effect was reported.

In conclusion, an essentially lifetime feeding study which was designed
and conducted in a fashion similar to those in the NCI's bioassay program has
yielded data strongly supporting the conclusion that the chronic feeding of
high doses of Type A Zeolite does not produce cancer or chronic organ toxicity
in rodents.
No carcinogenic or fibrogenic effects were observed in rats exposed to

~ a.» 444."
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=20 mg/m3 of Type A Zeolite, for three days per week, 5 hours per day

22 months.

for

The only compound related effect observed was the presence of the

test material in the alveolar macrophage and the lymph nodes, indicative of
detoxification mechanisms for airborne foreign insoluble particulate matter.
No carcinogenic effects were observed in rats given a single 50 mg
intraperitoneal injection of quartz or Type A Zeolite and then observed for
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various time periods up

to 24 months.

Under the above dosing conditions, Type

A Zeolite produced a fibrogenic response within the peritoneal
cavity.
The
response was qualitatively and quantitatively diffe
rent from the fibrogenic

response produced by quartz.

Specifically, the response observed with Type A
Zeolite regressed with time, whereas the response after
administration of
quartz progressed with time. Unpublished, preliminar
y studies, utilizing this
technique in mice, found that an intraperitoneal injec
tion of 20 mg of fibrous
natural zeolite resulted in the production of mesotheliomas
in less than one

year (Personal Communication

Dr. I. Selikoff).

It is thus a valid model to

indicate carcinogenic or toxic potential of relatively insolu
ble materials.

The effects of chronic inhalation of Zeolite A containing
detergent
formulations were studied in monkeys exposed to 1 and
6mg/m3 of these
materials. Exposure was for 6 hrs/day, 5 days per week
for 104 weeks. None
of the test materials had adverse effects on body weigh
t gain, hematology,
serum chemistry or urinalysis. The only alteration in
pulmonary function was
noted in monkeys treated with quartz. Histopathologic
al examination of the
various tissues indicated that exposure to approximat
ely 1 and 6 mg/m3 of
Type A Zeolite, or detergent formulations with Zeolite A
produced only an
increase in alveolar and septal macrophages, and
the expected response to
inhaled insoluble particulate matter.
These inhalation studies in monkeys

support the conclusion that chronic exposure to Type
A Zeolite dusts
negligible health hazard.

poses a

cerevisiae, nor did these two silicon materials
produce significant
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Silicon dioxide and hydrated calcium silicate did
not induce mutations in
the host mediated assay with Salmonella typhimurium
or Saccharomyces

_. _/\

No mutagenicity tests on Type A Zeolite have been
reported. Food grade
sodium aluminosilicate has been found non-mutagenic in
host mediated assays
with Salmonella typhimurium and Saccharomyces cerev
isiae as well as a dominant
lethal assay in which male rats were intubated with 4.25,
42.5 or 425 mg/kg of
sodium aluminosilicate daily for 5 days prior to
mating.

___,-

Mutagenicity

aberrations in the bone marrow metaphase chromosomes of rats; nor did they
produce abnormal changes in anaphase chromosomes of human embryonic lung cells
in tissue culture.

Based on the fact that other silicates are non-mutagenic, it is unlikely
that Type A Zeolite would be positive in mutagenicity tests.
Teratology

In the rat teratology study, dams were given either 74 mg/kg or 1600 mg/kg
Type A Zeolite by gavage on days 6-15 of gestation inclusive. In the rabbit
teratology study, dams were given 74 mg/kg, 345 mg/kg or 1600 mg/kg of Type A
Zeolite on days 6 through 18 of gestation.

Like other silicates, Type A

Zeolite has a teratogenic potential comparable to food grade sodium
aluminosilicate.
Conclusions

The toxicological data base on Type A Zeolite is much more extensive than
that available for other synthetic and natural silicates, even those used
the food industry.

by

Type A Zeolite is essentially non-toxic via oral, dermal,

ocular and respiratory routes of exposure and adverse effects are noted only
after oral doses several million times that of calculated human exposures.

These effects are similar to those noted after administration of massive oral
doses of other widely used silicates (e.g. magnesium trisilicate, food grade
sodium aluminosilicate and sodium silicate).

Laboratory and environmental studies have shown that man will

not be

exposed to cuboidal Type A Zeolite, only to soluble silicates and insoluble
aluminates (clay-like material).

Extensive metabolic studies have shown that

only the silicate, but not the aluminate, moiety of Type A Zeolite is

absorbed; supporting the conclusion that the oral toxicity of Type A Zeolite
is that of soluble silicate.
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The median level of Si02 in drinking water is 7 mg/L. Assumi
ng an
exaggerated use pattern for Type A Zeolite in detergents, this level
of
silicon will increase by less than 0.001%.
During animal studies, marked histopathological lesions were
noted only in
the kidney and bladder from animals fed diets containing Type
A Zeolite at
levels exceeding 0.125 percent. Such dose levels lead to increas
ed
particulate silicon and frank kidney and bladder stones after
90 days.

Naturally occurring levels of silicon in drinking water (up to 10
mg/mL) have

not been shown to lead to detectable levels of urinary
particulate silicon.

Type A Zeolite is not a teratogen and is not carcinogenic orally
or via

the inhalation route of exposure.

The negative mutagenic activity noted in

other silicates make it highly unlikely that Type A Zeolite
poses a mutagenic
hazard.
As with other builders, based on present knowledge and using current
state-of-the-art techniques of toxicological assessment, it is conclud
ed that
the use of Type A Zeolite in detergents will not pose a health
hazard to
humans.
Summary

Aluminosilicates are widely utilized in the food industry and in
treating
drinking water, not posing a human health hazard under current conditi
ons of
use. Cubic Type A Zeolite, with a Na:Si:Al ratio of 1:1:1 is thermo
dynamically less stable than food grade aluminosilicate, with its corres
ponding

ratio of 1:1:13 rapidly forming insoluble aluminates and solubl
e silicates in
aqueous suspensions at a pH <8, hence rarely being found in the environ
ment.
Type A Zeolite is essentially non-toxic in acute and chronic
toxicity
tests on animals, the behaviour being representative of the
silicates formed

on hydrolysis.

No carcinogenic or teratogenic effects were/noted after

exposure of experimental animals to high levels of Type A Zeolit
e and it is
unlikely to produce mutagenic effects.

Considering the normal exposure of man to natural silicon compoun
ds

without evident health hazards and the miniscule increase in silicon levels
in
drinking water resulting from the proposed use of Type A Zeolite in
detergents, the Task Force concludes that use of this zeolite in detergents is
not anticipated to lead to adverse human health effects.
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APPENDIX A

1

TERMS OF REFERENCE

i
T

for the
TASK FORCE
on the

HEALTH EFFECTS OF NON-NTA DETERGENT BUILDERS
The Science Advisory Board, formeriy the Research Advisory Board, has
previousiy investigated and made recommendations regarding the environmentai
and human heaTth impact of the use of NTA as a detergent budeer. A task
force is now working on the environmentai impact of the non-NTA detergent
budeers. The Task Force on the Heaith Effects of Non-NTA Detergent Buiiders
shoqu review the approaches used by the Task Force on HeaTth Effects of NTA
and the Task Forces on the Environmentai Effects of NTA and Non-NTA Detergent
Budeers, respectiveiy,

in order to maintain some consistency in approach.

The Task Force on the Heaith Effects of Non-NTA Detergent Budeers is
charged to:
i

a

A.

(1)

determine the chemicaTs which are currentTy in use as detergent

(2)

determine those chemicaTs which are TikeTy to be used in the
near future; and

(3)

appraise what is known and what is unknown about the heaith
effects of the substances Tisted in 1 and 2.

budeers;

B.

The task force wi11 advise the Science Advisory Board regarding their
overaTT appraisaT of the impact on human health of the non-NTA
detergent builders and any specific areas which require additiona]
research.

C.

These tasks are to be compieted by January 1, 1979, with an interim
report on May 1, 1978.
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l
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HEALTH EFFECTS OF NON-NTA DETERGENT BUILDERS

l
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Dr. Walter L. Schleyer
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hm James H. Day

lHead, Division of Allergy

lmpartment of Medicine
(meen's University
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PQ Corp., P.0. Box 258
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Lafayette Hill, Penn. 19444

l

Tar. e. c. Becking
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Mpt. of National Health and Welfare
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Dr. R. Tardiff
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National Academy of Sciences
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l
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Environmental Surveillance

Dr. S. I. Shibko
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Division of Toxicology, HFF-195

Food and Drug Administration
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Washington, D.C. 20204

hofessor R. O'Brien
Mfice of the Provost

iWiversity of Rochester
Mchester, New York

Dr. Raymond E. Shapiro
Asst. Director for Toxicology

14627

\
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Professor
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imngston, Ontario

20418

K7L 2N6

'\
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'W. F. Alan Brownridge
Manager
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Hamilton, Ontario L8N 3L5

Coordination, NIEHS

P.O. Box 12233
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27709

FORMER MEMBERS
Dr. David Gaylor (Until Dec., 1978)
Statistician
National Center for Toxicological Research
Jefferson, Arkansas 72079
Dr. R.A. Goyer (Until Feb., 1979)
Formerly: Chairman and Professor
Department of Pathology
University of Western Ontario
London, Ontario N6A 5C2
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Dr. G.J. Stopps (Until Sept., 1978)

Department of Preventive Medicine
and Pesticides

University of Toronto

Toronto, Ontario

M55 1A1

Secretariat Responsibilities
Dr. A. E. P. Watson
Research Scientist

Great Lakes Regionai Office

Internationai Joint Commission

100 Oueiiette Avenue, 8th Fioor

Windsor, Ontario

N9A 6T3

APPENDIX C
TERMS OF REFERENCE FOR THE SCIENCE ADVISORY BOARD
As used herein, Aresearch" includes development, demonstration and
research actiVities, but does not include regular monitoring and
surveillance of water quality.
The functions and responsibilities of the Science Advisory Board relating
to research activities in Canada and the United States concerning the
quality of the waters of the Great Lakes System shall be as follows:
(a)

to review at regular intervals these research activities in order to:

(i)
(ii)
(iii)

(iv)

examine the adequacy and reliability of research results,

their dissemination, and the effectiveness of their
application;

identify deficiencies in their scope, and inadequacies in
their funding and in completing schedules;
identify additional research projects that should be
undertaken;

identify specific research programs for which international
cooperation will be productive;

(b)

to provide advice and consolidations of scientific opinion to the
Commission and its boards on particular problems referred to the
Advisory Board by the Commission or its boards;

(c)

to facilitate both formal and informal international cooperation and
coordination of_research; and

(d)

to make recommendations to the Commission.

The Science Advisory Board on its own authority may seek analyses,

assessments and recommendations from other professional, academic,

governmental or intergovernmental groups about the problems of Great Lakes
water quality research and related research activities.
The IJC shall determine the size and composition of the Science Advisory

Board. The Commission should appoint members to the Advisory Board from
appropriate Federal, State and Provincial Government agencies and from
other agencies, organizations and institutions involved in Great Lakes
research activities. In making these appointments the Commission should
consider individuals from the academic, scientific and industrial

communities and the general public. Membership should be based primarily
upon an individual's qualifications and potential contribution to the work
of the Advisory Board.
The Science Advisory Board should work at all times in close cooperation
with the Great Lakes Water Quality Board.
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MEMBERSHIP, SCIENCE ADVISORY BOARD
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Dr. Donald 1. Mount (Chairman)
Environmental Research Laboratory
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Great Lakes Fishery Laboratory
1451 Green Road

Ann Arbor, Michigan

Niagara Falls, New York

14302

Dr. Lawrence w. Libby

Associate Professor
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Michigan State University
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Sea Grant Institute Program
University of Wisconsin-Madison
1800 University Avenue
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Canadian Section

Dr. G. K. Rodgers (Chairman)

Director
National Water Research Institute
Canada Centre for Inland Waters
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Wastewater Laboratory
U.S. EPA
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Cincinnati, Ohio 45268

P.0. Box 5050

Burlington, Ontario
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Mr. Paul D. Foley
Coordinator, Development & Research Group
Pollution Control Branch
Ontario Ministry of the Environment
135 St. Clair Avenue West
Toronto, Ontario M4V 1P5

Dr. John R. Sheaffer
President
Sheaffer and Roland, Inc.
130 North Franklin
Chicago, Illinois 60606

Professor J. Llamas
Director, Water Resources Center

Dr. Anne Specie
Department of Forestry and Natural

Faculty of Science and Engineering
Pavillon Pouliot

Resources

Purdue University
West Lafayette, Indiana

Dr. Mitchell R. Zavon
Medical Director
Hooker Chemicals
222 Rainbow Blvd. North
P.0. Box 728

University of Laval
Centreau, Room 3717

47907

Ste. Foy, Quebec
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433021
Dr. J. R. Vallentyne

Senior Scientist
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Ontario Region
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P.O. Box 5050
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Great Lakes Fishery Commission
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Executive Secretary
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International Association for

Great Lakes Research (IAGLR)

Dr. James H. Day
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Department of Medicine
Queen's University

Kingston, Ontario
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Dr. R. A. Sweeney
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Biology Professor
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